Pressure-overload and exercise-induced hypertrophy utilize different regulatory mechanisms for substrate selection and oxidation, suggesting fatty acid oxidation regulation as a potential therapeutic target in pathological hypertrophy.
Answers are grounded in this paper and cite their sources.
Lacks clinical data; leaves open fatty acid oxidation regulation as a hypertrophy target pending human validation.
Hypertrophy can be induced by pressure-overload or treadmill running. Pressure-overload-hypertrophy is associated with distinct changes in gene expression. The regulatory mechanisms in exercise-induced-hypertrophy are largely unknown. Objective: To compare the expression of metabolic genes and their regulators in exercise-induced- and pressure-overload-hypertrophy. Methods: Exercise-induced-hypertrophy was induced by treadmill-running of male Sprague Dawley rats for 10 weeks. Pressure-overload-hypertrophy was induced by aortic banding for 14 days. Contractile function was assessed by echocardiography. Expression of glucose (GO) and fatty acid oxidation (FAO) genes, as well as regulators of metabolic gene expression, were assessed by RT-PCR. Results: Both interventions caused significant hypertrophy (heart-to-body-weight-ratio +17,0% Banding, +14,3% Exercise, p<0.05) without affecting left ventricular function (normal EF). Contrary to expectations, exercise-induced-hypertrophy was not associated with any changes in the expression of FAO genes or the PPARalpha-coactivators (PGC)-1alpha and -1beta. In contrast, pressure-overload showed a clear trend towards reduced expression of FAO-genes (MCAD –43% p<0.05, LCAD –20% p<0.05, FABP –26% p<0.01, CPT1–20%, FATP –19%), accompanied by reduced expression of PGC-1alpha and -1beta (–40% and –35%, respectively, p<0.01). Expression of putative suppressors of PGC-1alpha was either unchanged or reduced in both forms of hypertrophy (Akt, H11K, Cdk9, HIF1alpha). Conclusions: Pressure-overload- and exercise-induced-hypertrophy appear to have different regulatory mechanisms governing substrate selection and oxidation. The lack of major differences in expression patterns after treadmill running may be a reflection of a new steady-state of gene expression as part of a physiological hypertrophic response. Pharmacologic targeting of FAO-regulation may be attractive for preventing failure in pathologically hypertrophied hearts.
No takes yet. Share an insight, caveat, or question.
Schwarzer et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: